A Phase I/II Study of IPH1101 (BrHPP), Specific Agonist of V gamma 9V delta 2 T Lymphocytes, in Combination with Rituximab Re-Treatment in Patients with Follicular Lymphoma. Interim Phase I Data.

Laurent, Guy; Van Den Neste, Eric; Rossi, Jean Francois; Audibert, Fabien; Ghesquieres, Herve; Le Gouill, Steven; Feugier, Pierre; Sicard, Helene; Ingoure, Sophie; Soule, Elodie; de Micheaux, Sylvie Lafaye

A Phase I/II Study of IPH1101 (BrHPP), Specific Agonist of V gamma 9V delta 2 T Lymphocytes, in Combination with Rituximab Re-Treatment in Patients with Follicular Lymphoma. Interim Phase I Data.

Laurent, Guy

;

Van Den Neste, Eric

;

Rossi, Jean Francois

;

Audibert, Fabien

;

de Micheaux, Sylvie Lafaye

;et.al.

(2008) 50th Annual Meeting of the American- Society-of-Hematology — Location: San Francisco (Ca) (6.December.2008)

Files

No attached file found for this publication.

Details

Authors

Laurent, Guy
Author
Van Den Neste, EricUCLouvain
Author
Rossi, Jean Francois
Author
Audibert, Fabien
Author
de Micheaux, Sylvie Lafaye
Author

Affiliations

Citations

APA
Chicago
FWB

Laurent, G., Van Den Neste, E., Rossi, J. F., Audibert, F., Ghesquieres, H., Le Gouill, S., Feugier, P., Sicard, H., Ingoure, S., Soule, E., & de Micheaux, S. L. (2008). A Phase I/II Study of IPH1101 (BrHPP), Specific Agonist of V gamma 9V delta 2 T Lymphocytes, in Combination with Rituximab Re-Treatment in Patients with Follicular Lymphoma. Interim Phase I Data. Blood, 112(11), 369. https://hdl.handle.net/2078.5/67838 (Original work published 2008)